BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 10221847)

  • 41. Radioprotection of craniofacial bone growth.
    Gevorgyan A; La Scala GC; Neligan PC; Pang CY; Forrest CR
    J Craniofac Surg; 2007 Sep; 18(5):995-1000. PubMed ID: 17912071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid against induction of altered hepatocyte foci in rats treated once with gamma-radiation within one day after birth.
    Grdina DJ; Peraino C; Carnes BA; Hill CK
    Cancer Res; 1985 Nov; 45(11 Pt 1):5379-81. PubMed ID: 2865003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is growth hormone a radioprotective agent?
    Tekin SB; Ertekin MV; Erdogan F; Sezen O; Karslioglu I; Gepdiremen A; Serifoglu K; Altas S
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):293-8. PubMed ID: 16503890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Future development of amifostine as a radioprotectant.
    Werner-Wasik M
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):129-34. PubMed ID: 10348272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new orally active, aminothiol radioprotector-free of nausea and hypotension side effects at its highest radioprotective doses.
    Soref CM; Hacker TA; Fahl WE
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e701-7. PubMed ID: 22330992
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study on the protection profile of lidocaine, amifostine, and pilocarpin on the parotid gland during radiotherapy.
    Hakim SG; Kosmehl H; Lauer I; Nadrowitz R; Wedel T; Sieg P
    Cancer Res; 2005 Nov; 65(22):10486-93. PubMed ID: 16288041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
    Milas L; Hunter N; Reid BO; Thames HD
    Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PREVENTION OF RADIATION-INDUCED RETINOPATHY WITH AMIFOSTINE IN WISTAR ALBINO RATS.
    Akkus Yildirim B; Çetin E; Topkan E; Ozyigit G; Cengiz M; Surucu S; Usubutun A; Akyol F
    Retina; 2015 Jul; 35(7):1458-64. PubMed ID: 25768249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radioprotection With Amifostine Enhances Bone Strength and Regeneration and Bony Union in a Rat Model of Mandibular Distraction Osteogenesis.
    Tchanque-Fossuo CN; Donneys A; Deshpande SS; Sarhaddi D; Nelson NS; Monson LA; Dahle SE; Goldstein SA; Buchman SR
    Ann Plast Surg; 2018 Feb; 80(2):176-180. PubMed ID: 28930778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amifostine has an inhibitory effect on the radiation-induced p53-branched cascade in the immature mouse ovary.
    Yoon YD; Kim JH; Lee KH; Kim JK
    In Vivo; 2005; 19(3):509-14. PubMed ID: 15875769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening of protective effect of amifostine on radiation-induced structural and functional variations in rat liver microsomal membranes by FT-IR spectroscopy.
    Cakmak G; Zorlu F; Severcan M; Severcan F
    Anal Chem; 2011 Apr; 83(7):2438-44. PubMed ID: 21410135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Site-specific effects of cerivastatin on bone in male Sprague-Dawley rats.
    Banu J; Kalu DN
    Bone; 2004 Mar; 34(3):432-42. PubMed ID: 15003791
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.
    Anné PR
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):80-3. PubMed ID: 12577250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radioprotective effect of a metalloporphyrin compound in rat eye model.
    Mao XW; Crapo JD; Mekonnen T; Lindsey N; Martinez P; Gridley DS; Slater JM
    Curr Eye Res; 2009 Jan; 34(1):62-72. PubMed ID: 19172472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Change in cerebral microcirculation at long-term periods following irradiation with protection by gammaphos].
    Plotnikova ED; Levitman MKh; Shaposhnikova VV; Eĭdus LKh
    Med Radiol (Mosk); 1983 Jul; 28(7):19-22. PubMed ID: 6308381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radioprotective effect of amifostine on parotid gland functioning is region dependent.
    Konings AW; Faber H; Vissink A; Coppes RP
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1584-91. PubMed ID: 16297717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
    Milas L; Hunter N; Stephens LC; Peters LJ
    Cancer Res; 1984 Dec; 44(12 Pt 1):5567-9. PubMed ID: 6093999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [On the influence of a radioprotective substance on bone growth damage in rats].
    Irie H; Yosihara H; Osiumi Y
    Strahlentherapie; 1966 Jan; 129(1):112-7. PubMed ID: 5983022
    [No Abstract]   [Full Text] [Related]  

  • 59. Protective effect of pentoxifylline on growth plate in neonatal rats following long-term phototherapy.
    Atabek ME; Pirgon O; Esen HH
    Pediatr Res; 2007 Aug; 62(2):163-6. PubMed ID: 17597644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radioprotection of human endothelial cells with amifostine.
    Andreopoulos D; Schleicher UM; Cotarelo CL; Hand S; Ammon J
    Strahlenther Onkol; 1999 Nov; 175 Suppl 4():34-6. PubMed ID: 10584139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.